<?xml version="1.0" encoding="UTF-8"?>
<ref id="B52-ijms-21-01376">
 <label>52.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Abdelaziz</surname>
    <given-names>M.O.</given-names>
   </name>
   <name>
    <surname>Ossmann</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Kaufmann</surname>
    <given-names>A.M.</given-names>
   </name>
   <name>
    <surname>Leitner</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Steinberger</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Willimsky</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Raftery</surname>
    <given-names>M.J.</given-names>
   </name>
   <name>
    <surname>Sch√∂nrich</surname>
    <given-names>G.</given-names>
   </name>
  </person-group>
  <article-title>Development of a human cytomegalovirus (HCMV)-based therapeutic cancer vaccine uncovers a previously unsuspected viral block of MHC class I antigen presentation</article-title>
  <source>Front. Immunol.</source>
  <year>2019</year>
  <volume>10</volume>
  <fpage>1776</fpage>
  <pub-id pub-id-type="doi">10.3389/fimmu.2019.01776</pub-id>
  <?supplied-pmid 31417555?>
  <pub-id pub-id-type="pmid">31417555</pub-id>
 </element-citation>
</ref>
